Friday, July 31, 2026

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

North Korea Halts Border Propaganda After South Suspends Broadcasts

North Korea has halted loudspeaker broadcasts to South Korea; military communication lines remain unresponsive amid ongoing drills.

U.S. Supreme Court Tariff Ruling Fallout: Why Section 232 Still Looms Over Batteries, Power Grids, and Telecom

South Korea monitors U.S. tariff developments post-Supreme Court ruling, clarifying no new national security tariffs announced yet.

Tag: Coupang crisis

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.